Article
Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Histopathology - 1 Aug 2013
Lehnen Nils C, von Mässenhausen Anne, Kalthoff Holger, Zhou Hui, Glowka Tim, Schütte Ute, Höller Tobias, Riesner Katarina, Boehm Diana, Merkelbach-Bruse Sabine, Kirfel Jutta, Perner Sven, Gütgemann Ines
Abstract excerpt
AIMS: Pancreatic ductal adenocarcinomas (PDACs) are chemoresistant, resulting in extremely poor survival of patients; therefore, novel molecular targets, even in small subsets of genetically characterized tumours, are urgently needed. Tyrosine kinase receptor inhibitors (TKIs) are already in clinical use. The aims of this study were to examine the gene copy number and expression of fibroblast growth factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
